Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis.

MLA

Shiffman, Dov, et al. “Use of Low Density Lipoprotein Particle Number Levels as an Aid in Statin Treatment Decisions for Intermediate Risk Patients: A Cost-Effectiveness Analysis.” BMC Cardiovascular Disorders, vol. 16, no. 1, Dec. 2016, p. 251. EBSCOhost, https://doi.org/10.1186/s12872-016-0429-6.

APA

Shiffman, D., Arellano, A. R., Caulfield, M. P., Louie, J. Z., Bare, L. A., Devlin, J. J., & Melander, O. (2016). Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis. BMC Cardiovascular Disorders, 16(1), 251. https://doi.org/10.1186/s12872-016-0429-6

Chicago

Shiffman, Dov, Andre R Arellano, Michael P Caulfield, Judy Z Louie, Lance A Bare, James J Devlin, and Olle Melander. 2016. “Use of Low Density Lipoprotein Particle Number Levels as an Aid in Statin Treatment Decisions for Intermediate Risk Patients: A Cost-Effectiveness Analysis.” BMC Cardiovascular Disorders 16 (1): 251. doi:10.1186/s12872-016-0429-6.